|
|
||||
 | ||||
|
|
Select from the search options to widen or narrow the search results.
The TRA2P study is a research study that will look at a new medication for the prevention of atherothrombotic events in people with a history of heart disease or stroke. To particpate in the TRA2P study, you must
For more information, please contact Deb Seaton, RN at 414-649-3929 or by email at dseaton@hrtcare.com Principal Investigator: Dr. Anjan Gupta Clinical trial location(s)Private Physician's Office,
[ previous page ]
|
||
 |
||||
 |
 |
 |
|
 |
